Kim Yoo Jin, Malhi Jasmine, Trost Jeff, Leucker Thorsten, Virani Salim S, Newby L Kristin, Blumenthal Roger S, Hariri Essa
Department of Medicine, Johns Hopkins University, Baltimore, MD.
Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University, Baltimore, MD.
Am J Med. 2025 Feb;138(2):204-208. doi: 10.1016/j.amjmed.2024.09.013. Epub 2024 Sep 14.
The 2023 American Heart Association (AHA)/American College of Cardiology (ACC) Multisociety Guideline for the Management of Patients with Chronic Coronary Disease presents important updates to the care of patients with chronic coronary disease. The recommendations of these guidelines inform the care for patients with 1) asymptomatic coronary artery disease, 2) stable angina or equivalent symptoms (e.g., dyspnea upon exertion), 3) symptomatic nonobstructive coronary disease including coronary microvascular dysfunction and vasospasm, and 4) left ventricular (LV) systolic dysfunction with known coronary artery disease. In this review, we aim to demonstrate key recommendations in the 2023 guideline using the following four hypothetical cases.
《2023年美国心脏协会(AHA)/美国心脏病学会(ACC)慢性冠状动脉疾病患者管理多学会指南》对慢性冠状动脉疾病患者的护理提出了重要更新。这些指南的建议为以下患者的护理提供了依据:1)无症状冠状动脉疾病;2)稳定型心绞痛或等效症状(如运动时呼吸困难);3)有症状的非阻塞性冠状动脉疾病,包括冠状动脉微血管功能障碍和血管痉挛;4)已知患有冠状动脉疾病的左心室(LV)收缩功能障碍。在本综述中,我们旨在通过以下四个假设病例展示2023年指南中的关键建议。